Susquehanna International Group’s Opus Genetics IRD Stock Holding History

Susquehanna International Group’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$370K	Buy	81,400 +35,200	+76%	+$122K	﹤0.01%	10402
2025 Q4	$92.9K	Buy	+46,200	New	+$93.8K	﹤0.01%	11492
2024 Q1	–	Sell	-14,100	Closed	-$42.4K	–	13574
2023 Q4	$42.4K	Buy	+14,100	New	+$41.7K	﹤0.01%	11777
2023 Q3	–	Sell	-150,600	Closed	-$654K	–	13177
2023 Q2	$654K	Buy	+150,600	New	+$715K	﹤0.01%	7686
2022 Q4	–	Sell	-209,000	Closed	-$420K	–	13901
2022 Q3	$420K	Sell	209,000 -12,500	-6%	-$27K	﹤0.01%	8939
2022 Q2	$425K	Buy	221,500 +208,500	+1,604%	+$474K	﹤0.01%	8673
2022 Q1	$42K	Sell	13,000 -80,500	-86%	-$276K	﹤0.01%	12388
2021 Q4	$349K	Buy	93,500 +36,500	+64%	+$146K	﹤0.01%	10119
2021 Q3	$294K	Buy	+57,000	New	+$263K	﹤0.01%	10649
2019 Q3	–	Sell	-3,525	Closed	-$73K	–	10954
2019 Q2	$73K	Buy	3,525 +3,231	+1,099%	+$73K	﹤0.01%	9734
2019 Q1	$7K	Sell	294 -66	-18%	-$2.19K	﹤0.01%	8669
2018 Q4	$16K	Sell	360 -146	-29%	-$8.53K	﹤0.01%	8708
2018 Q3	$43K	Sell	506 -77	-13%	-$5.95K	﹤0.01%	8885
2018 Q2	$39K	Buy	+583	New	+$51.2K	﹤0.01%	9327

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Susquehanna International Group's IRD Position: Q1 2026 in Review

Susquehanna International Group increased its Opus Genetics (IRD) stake by 308% in Q1 2026, buying an estimated $2.15M and bringing the position to 823,383 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #4803.

Susquehanna International Group first reported a position in IRD in Q4 2014 and has held it in 23 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Susquehanna International Group held 823,383 shares of Opus Genetics worth $3.75M as of Q1 2026.
Susquehanna International Group bought 621,748 Opus Genetics shares in Q1 2026, an estimated $2.15M.
Opus Genetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4803 holding.
Susquehanna International Group first reported a position in Opus Genetics in Q4 2014 and has held it in 23 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.